A Randomized Double Blind Placebo Controlled Single Institution Phase 2 Study of Metformin in Patients Undergoing Active Surveillance for Prostate Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary)
- Indications Prostate cancer
- Focus Pharmacogenomic; Therapeutic Use
- 24 May 2013 Biomarkers information updated
- 23 May 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 27 Dec 2012 New trial record